ConductScience.org, home

Trial · NCT00847379

Results by group351

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Number of Participants With Treatment-Emergent Adverse Events (AEs)High-Dose Ataluren/High-Dose AtalurenAny AEs52Participants
Number of Participants With Treatment-Emergent Adverse Events (AEs)Low-Dose Ataluren/High-Dose AtalurenAny AEs49Participants
Number of Participants With Treatment-Emergent Adverse Events (AEs)Placebo/High-Dose AtalurenAny AEs48Participants
Number of Participants With Treatment-Emergent Adverse Events (AEs)Overall Participants: High-Dose AtalurenAny AEs149Participants
Number of Participants With Treatment-Emergent Adverse Events (AEs)High-Dose Ataluren/High-Dose AtalurenDrug-related AEs10Participants
Number of Participants With Treatment-Emergent Adverse Events (AEs)Low-Dose Ataluren/High-Dose AtalurenDrug-related AEs10Participants
Number of Participants With Treatment-Emergent Adverse Events (AEs)Placebo/High-Dose AtalurenDrug-related AEs22Participants
Number of Participants With Treatment-Emergent Adverse Events (AEs)Overall Participants: High-Dose AtalurenDrug-related AEs42Participants
Number of Participants With Treatment-Emergent Adverse Events (AEs)High-Dose Ataluren/High-Dose AtalurenSerious AEs0Participants
Number of Participants With Treatment-Emergent Adverse Events (AEs)Low-Dose Ataluren/High-Dose AtalurenSerious AEs1Participants
Number of Participants With Treatment-Emergent Adverse Events (AEs)Placebo/High-Dose AtalurenSerious AEs2Participants
Number of Participants With Treatment-Emergent Adverse Events (AEs)Overall Participants: High-Dose AtalurenSerious AEs3Participants
Number of Participants With Treatment-Emergent Adverse Events (AEs)High-Dose Ataluren/High-Dose AtalurenMild AEs34Participants
Number of Participants With Treatment-Emergent Adverse Events (AEs)Low-Dose Ataluren/High-Dose AtalurenMild AEs23Participants
Number of Participants With Treatment-Emergent Adverse Events (AEs)Placebo/High-Dose AtalurenMild AEs26Participants
Number of Participants With Treatment-Emergent Adverse Events (AEs)Overall Participants: High-Dose AtalurenMild AEs83Participants
Number of Participants With Treatment-Emergent Adverse Events (AEs)High-Dose Ataluren/High-Dose AtalurenModerate AEs13Participants
Number of Participants With Treatment-Emergent Adverse Events (AEs)Low-Dose Ataluren/High-Dose AtalurenModerate AEs22Participants
Number of Participants With Treatment-Emergent Adverse Events (AEs)Placebo/High-Dose AtalurenModerate AEs19Participants
Number of Participants With Treatment-Emergent Adverse Events (AEs)Overall Participants: High-Dose AtalurenModerate AEs54Participants

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00847379/results